Top Stories
-
With a new three-year, $775,000 Translational Research Program grant by The Leukemia & Lymphoma Society, Dr. Lentzsch and collaborators unveil a promising new approach to treat multiple myeloma.
Topic
-
March is Multiple Myeloma Awareness month, and in this Q+A, Dr. Rajshekhar Chakraborty takes us through where we are today in multiple myeloma research and treatment.
-
Dr. Suzanne Lentzsch and her team have recently identified a promising new drug target in a subset of multiple myeloma cases, those with RAS mutations. The research was published in the journal Blood.
-
Rajshekhar Chakraborty, MD, and Shawn Sarkaria, MD, two new faculty members at Columbia University Irving Medical Center, have joined the Multiple Myeloma Center.
Latest News
- February 24, 2020
A new clinical trial for AL amyloidosis is paving the way for a promising new treatment option for patients with the rare organ-debilitating disease.
Topic
